Literature DB >> 17123120

Tacrolimus-induced HUS: an unusual cause of acute renal failure in nephrotic syndrome.

Vinod Baburaj Pandirikkal1, Manoj Jain, Sanjeev Gulati.   

Abstract

Acute renal failure (ARF) is an uncommon complication in children with nephrotic syndrome. We report here the case of a 10-year-old male child with primary steroid-resistant nephrotic syndrome who was non-responsive to steroids and cyclophosphamide. A kidney biopsy revealed that he had focal segmental glomerulosclerosis. His treatment was initiated with tacrolimus (dose of 0.15 mg/kg/day) in two divided doses along with prednisolone 60 mg/m(2)/daily. After 1 month of treatment, he was diagnosed as having acute renal failure secondary to HUS. This was postulated to be due to the tacrolimus therapy, which was withdrawn. Two weeks after stopping the adminsitration of tacrolimus, his urine output improved, and the hemoglobin and serum creatinine normalized. Thus, tacrolimus-induced HUS is a rare cause of ARF in nephrotic syndrome. With the increasing use of tacrolimus in steroid-resistant nephrotic syndrome, the treating physicians need to be aware of this rare, but potentially life-threatening side effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17123120     DOI: 10.1007/s00467-006-0265-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

Review 1.  Pathophysiology of acute renal failure in idiopatic nephrotic syndrome.

Authors:  H A Koomans
Journal:  Nephrol Dial Transplant       Date:  2001-02       Impact factor: 5.992

2.  Mycophenolate mofetil as an effective alternative to cyclosporin in post-transplant haemolytic uraemic syndrome.

Authors:  D K Agarwal; S Gulati; A Mehta; A Kumar; R K Sharma; B Mehta; A Gupta; R K Gupta
Journal:  Nephrol Dial Transplant       Date:  2000-12       Impact factor: 5.992

3.  FK-506 and haemolytic uraemic syndrome.

Authors:  Z Brown; G H Neild
Journal:  Lancet       Date:  1990-02-17       Impact factor: 79.321

4.  Hemolytic-uremic syndrome in a renal transplant recipient on FK 506 immunosuppression.

Authors:  R J Schmidt; K K Venkat; F Dumler
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 5.  New aspects of the treatment of nephrotic syndrome.

Authors:  A Schwarz
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

6.  Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.

Authors:  Paula Frassinetti Castelo Branco Camurça Fernandes; Geraldo Bezerra Da Silva; Fernando A De Sousa Barros; Claudia M Costa Oliveira; Marcos Kubrusly; João B Evangelista
Journal:  J Nephrol       Date:  2005 Nov-Dec       Impact factor: 3.902

7.  [Acute renal failure in children with idiopathic nephrotic syndrome].

Authors:  K Kiliś-Pstrusińska; D Zwolińska; K Musiał
Journal:  Pol Merkur Lekarski       Date:  2000-07

Review 8.  FK506-associated thrombotic microangiopathy: report of two cases and review of the literature.

Authors:  H M Trimarchi; L D Truong; S Brennan; J M Gonzalez; W N Suki
Journal:  Transplantation       Date:  1999-02-27       Impact factor: 4.939

9.  Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome.

Authors:  Kim Loeffler; Manjula Gowrishankar; Verna Yiu
Journal:  Pediatr Nephrol       Date:  2004-02-03       Impact factor: 3.714

Review 10.  Tacrolimus-associated hemolytic uremic syndrome: a case analysis.

Authors:  Chih-Ching Lin; Kuang-Liang King; Yu-Wen Chao; An Han Yang; Chao-Fu Chang; Wu-Chang Yang
Journal:  J Nephrol       Date:  2003 Jul-Aug       Impact factor: 3.902

View more
  4 in total

Review 1.  Off-label use of tacrolimus in children with glomerular disease: Effectiveness, safety and pharmacokinetics.

Authors:  Guo-Xiang Hao; Lin-Lin Song; Dong-Feng Zhang; Le-Qun Su; Evelyne Jacqz-Aigrain; Wei Zhao
Journal:  Br J Clin Pharmacol       Date:  2020-01-14       Impact factor: 4.335

2.  Risk factors and clinical characteristics of tacrolimus-induced acute nephrotoxicity in children with nephrotic syndrome: a retrospective case-control study.

Authors:  Ping Gao; Xin-Lei Guan; Rui Huang; Xiao-Fang Shang-Guan; Jiang-Wei Luan; Mao-Chang Liu; Hua Xu; Xiao-Wen Wang
Journal:  Eur J Clin Pharmacol       Date:  2019-11-19       Impact factor: 2.953

3.  Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab.

Authors:  Megha Suri; Kim Tran; Ajay P Sharma; Guido Filler; Joanne Grimmer
Journal:  Int Urol Nephrol       Date:  2008-05-20       Impact factor: 2.370

4.  Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy.

Authors:  Kenji Ishikura; Shinsuke Matsumoto; Mayumi Sako; Kazushi Tsuruga; Koichi Nakanishi; Koichi Kamei; Hiroshi Saito; Shuichiro Fujinaga; Yuko Hamasaki; Hiroko Chikamoto; Yasufumi Ohtsuka; Yasuhiro Komatsu; Toshiyuki Ohta; Takuhito Nagai; Hiroshi Kaito; Shuji Kondo; Yohei Ikezumi; Seiji Tanaka; Yoshitsugu Kaku; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2015-02       Impact factor: 2.617

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.